Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2Phase 3 Interventional Results available

Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy

ClinicalTrials.gov ID: NCT00307164

Public ClinicalTrials.gov record NCT00307164. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 11:10 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II/III, Randomized, Double-Blind, Placebo-Controlled Trial of Uridine Supplementation in HIV Lipoatrophy

Study identification

NCT ID
NCT00307164
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
Enrollment
167 participants

Conditions and interventions

Interventions

  • NucleomaxX Drug
  • NucleomaxX placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2006
Primary completion
Nov 30, 2008
Completion
Nov 30, 2008
Last update posted
Nov 3, 2021

2006 – 2008

United States locations

U.S. sites
29
U.S. states
16
U.S. cities
23
Facility City State ZIP Site status
Alabama Therapeutics CRS Birmingham Alabama 35924-2050
USC CRS Los Angeles California 90033
UCLA CARE Center CRS Los Angeles California
Stanford CRS Palo Alto California 94305-5107
Ucsd, Avrc Crs San Diego California 92103
Harbor-UCLA Med. Ctr. CRS Torrance California 90502-2052
University of Colorado Hospital CRS Aurora Colorado 80262-3706
The Ponce de Leon Ctr. CRS Atlanta Georgia 30308
Univ. of Hawaii at Manoa, Leahi Hosp. Honolulu Hawaii 96816
Rush Univ. Med. Ctr. ACTG CRS Chicago Illinois 60612
Indiana Univ. School of Medicine, Infectious Disease Research Clinic Indianapolis Indiana 46202-5250
Johns Hopkins Adult AIDS CRS Baltimore Maryland 21287-8106
University of Minnesota, ACTU Minneapolis Minnesota 55455
Beth Israel Med. Ctr., ACTU New York New York 10003
NY Univ. HIV/AIDS CRS New York New York 10016-6481
Cornell CRS New York New York 10021
HIV Prevention & Treatment CRS New York New York 10032
Trillium Health ACTG CRS Rochester New York 14607
Univ. of Rochester ACTG CRS Rochester New York 14642-0001
Unc Aids Crs Chapel Hill North Carolina 27514
Duke Univ. Med. Ctr. Adult CRS Durham North Carolina 27710
Univ. of Cincinnati CRS Cincinnati Ohio 45267-0405
Case CRS Cleveland Ohio 44106-5083
MetroHealth CRS Cleveland Ohio 44109
The Ohio State University Medical Center Columbus Ohio 43210
Pitt CRS Pittsburgh Pennsylvania 15213-2582
The Miriam Hosp. ACTG CRS Providence Rhode Island 02906
Vanderbilt Therapeutics CRS Nashville Tennessee 37203
University of Washington AIDS CRS Seattle Washington 98104

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00307164, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2021 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00307164 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →